Mark Tengler
Vorstandsvorsitzender bei Spectrix Therapeutics LLC
Aktive Positionen von Mark Tengler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Vorstandsvorsitzender | 01.01.2016 | - |
Gründer | 01.01.2016 | - |
Karriereverlauf von Mark Tengler
Ehemalige bekannte Positionen von Mark Tengler
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NEOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 11.05.2011 | 01.03.2016 |
Präsident | 15.06.2009 | - | |
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology PharmaPrint, Inc. develops dietary supplements, functional foods, and pharmaceutical products from botanical sources. The private company is based in Irvine, CA. | Geschäftsführer | - | - |
Ausbildung von Mark Tengler
Colorado State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology PharmaPrint, Inc. develops dietary supplements, functional foods, and pharmaceutical products from botanical sources. The private company is based in Irvine, CA. | Health Technology |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Health Technology |
- Börse
- Insiders
- Mark Tengler
- Erfahrung